VA
EVH icon

Vident Advisory’s Evolent Health EVH Stock Holding History

Vident Advisory’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,588
Closed -$44.7K – 1969
2026
Q1 		$44.7K Buy
+19,588
New +$62.1K ﹤0.01% 1826
2025
Q4 		– Sell
-14,182
Closed -$120K – 1666
2025
Q3 		$120K Sell
14,182
-757
-5% -$7.35K ﹤0.01% 1593
2025
Q2 		$168K Buy
+14,939
New +$137K ﹤0.01% 1523

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Vident Advisory's EVH Position: Q2 2026 in Review

Vident Advisory sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 19,588 shares — an estimated $44.7K sold.

Vident Advisory first reported a position in EVH in Q2 2025 and held it in 3 quarters. The position peaked at $168K in Q2 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Vident Advisory reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
  • Vident Advisory sold 19,588 Evolent Health shares in Q2 2026, an estimated $44.7K.
  • Vident Advisory first reported a position in Evolent Health in Q2 2025 and held it in 3 quarters.
  • Vident Advisory's Evolent Health position peaked at $168K in Q2 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.